Search research articles
Contact Us
Filters
Showing results (1-10 of 69) with videos related to
Page
of 7
Sort By:
Molecular Therapy. Methods & Clinical Development
|
January 19, 2023
Chimeric engulfment receptors: A new cell therapy approach for SIV and HIV infection
Rimas J Orentas
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 23, 2013
Reading the tea leaves of tumor-mediated immunosuppression
Rimas J Orentas
Molecular Therapy. Methods & Clinical Development
|
March 6, 2024
A positive take on negative selection for CAR-T manufacturing
Rimas J Orentas
Critical Reviews in Oncogenesis
|
September 10, 2015
Emerging Immunotherapies for Cancer and Their Potential for Application in Pediatric Oncology
Rimas J Orentas, Crystal L Mackall
Acta Biochimica Et Biophysica Sinica
|
December 17, 2009
Discovery of YB-1 as a new immunological target in neuroblastoma by vaccination in the context of regulatory T cell blockade
Jin Zheng, Weiqing Jing, Rimas J Orentas
Cytokine
|
March 9, 2006
Tumor-derived macrophage migration inhibitory factor (MIF) inhibits T lymphocyte activation
Xiaocai Yan, Rimas J Orentas, Bryon D Johnson
Cellular Immunology
|
June 5, 2007
Cellular immune response to an engineered cell-based tumor vaccine at the vaccination site
Qiang Zhou, Bryon D Johnson, Rimas J Orentas
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 2, 2007
CD25+ regulatory T cell inhibition enhances vaccine-induced immunity to neuroblastoma
Bryon D Johnson, Weiqing Jing, Rimas J Orentas
Frontiers in Oncology
|
May 31, 2012
Immunotherapy targets in pediatric cancer
Rimas J Orentas, Daniel W Lee, Crystal Mackall
Seminars in Hematology
|
April 20, 2023
Place of care manufacturing of chimeric antigen receptor cells: Opportunities and challenges
Rimas J Orentas, Boro Dropulić, Marcos de Lima
Page
of 7
Search research articles
Search
Showing results (1-10 of 69) with videos related to
Sort By:
Page
of 7
Molecular Therapy. Methods & Clinical Development
|
January 19, 2023
Chimeric engulfment receptors: A new cell therapy approach for SIV and HIV infection
Rimas J Orentas
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 23, 2013
Reading the tea leaves of tumor-mediated immunosuppression
Rimas J Orentas
Molecular Therapy. Methods & Clinical Development
|
March 6, 2024
A positive take on negative selection for CAR-T manufacturing
Rimas J Orentas
Critical Reviews in Oncogenesis
|
September 10, 2015
Emerging Immunotherapies for Cancer and Their Potential for Application in Pediatric Oncology
Rimas J Orentas, Crystal L Mackall
Acta Biochimica Et Biophysica Sinica
|
December 17, 2009
Discovery of YB-1 as a new immunological target in neuroblastoma by vaccination in the context of regulatory T cell blockade
Jin Zheng, Weiqing Jing, Rimas J Orentas
Cytokine
|
March 9, 2006
Tumor-derived macrophage migration inhibitory factor (MIF) inhibits T lymphocyte activation
Xiaocai Yan, Rimas J Orentas, Bryon D Johnson
Cellular Immunology
|
June 5, 2007
Cellular immune response to an engineered cell-based tumor vaccine at the vaccination site
Qiang Zhou, Bryon D Johnson, Rimas J Orentas
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 2, 2007
CD25+ regulatory T cell inhibition enhances vaccine-induced immunity to neuroblastoma
Bryon D Johnson, Weiqing Jing, Rimas J Orentas
Frontiers in Oncology
|
May 31, 2012
Immunotherapy targets in pediatric cancer
Rimas J Orentas, Daniel W Lee, Crystal Mackall
Seminars in Hematology
|
April 20, 2023
Place of care manufacturing of chimeric antigen receptor cells: Opportunities and challenges
Rimas J Orentas, Boro Dropulić, Marcos de Lima
Page
of 7